SBI HEALTHCARE OPPORTUNITIES FUND
SBI Mutual Fund · Sectoral / Thematic · Direct Growth · AMFI 119783 · ISIN INF200K01UP2
NAV₹631.741620 Nov 2026
3Y return+24.78%a year
5Y return+20.90%a year
Expense ratio0.98%₹6,067 Cr
Growth Score88.4★★★★★
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | +12.98% | +5.38% | +17.06% | +30.30% | +27.26% | +24.78% | +20.90% | +25.59% | +16.13% | +18.44% |
| NIFTY Healthcare TRI | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Category middle | +7.16% | +0.76% | +8.62% | +4.78% | +4.45% | +14.50% | +13.44% | +17.71% | +15.62% | — |
Risk (36 months)
| Volatility | 14.11% |
| Sharpe | 1.30 |
| Sortino | 2.30 |
| Beta | 0.86 |
| Alpha | +5.05% |
| Deepest fall | -30.53% |
| 1-year periods with a loss | 29% |
| 5Y SIP XIRR | +24.10% |
Top holdings (31 Oct 2026)
| Sun Pharmaceutical Industries Ltd. | 10.55% |
| Divi's Laboratories Ltd. | 8.38% |
| Max Healthcare Institute Ltd. | 4.96% |
| Acutaas Chemicals Ltd. | 4.95% |
| Apollo Hospitals Enterprise Ltd. | 4.87% |
| Laurus Labs Ltd. | 4.76% |
| Cipla Ltd. | 4.36% |
| TREPS | 4.14% |
| Torrent Pharmaceuticals Ltd. | 4.11% |
| Aurobindo Pharma Ltd. | 3.10% |
| Gland Pharma Ltd. | 3.06% |
| Aster DM Quality Care Ltd. | 3.03% |
Sectors
| Pharmaceuticals & Biotechnology | 61.8% |
| Healthcare Services | 29.4% |
| Chemicals & Petrochemicals | 4.4% |
| Healthcare Equipment & Supplies | 1.5% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.